This inventor holds 1 USPTO granted patent. Top assignee: Allergan Holdings Unlimited Company. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations of J Michael Davenport in Opioid Receptor Modulation
Introduction
J Michael Davenport, an inventive mind located in Rockmart, GA, has made significant contributions to the field of pharmaceutical formulations. He is known for holding a patent related to opioid receptor modulators, designed to enhance safety and effectiveness in medication administration.
Latest Patents
Davenport's notable patent is titled "Opioid receptor modulator dosage formulations." This invention encompasses abuse deterrent solid dosage formulations containing a specific formulation of 5-({[2-Amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid, along with the associated processes for preparation and administration. This advancement is crucial in combating opioid abuse while providing effective pain relief.
Career Highlights
Currently, Davenport is associated with Allergan Holdings Unlimited Company, a prominent player in the pharmaceutical industry. His work there emphasizes the importance of innovation in drug formulation, particularly focusing on compliance and safety in opioid therapies. Davenport’s inventive efforts are not only technical but also reflect a commitment to public health and safety in drug use.
Collaborations
Davenport collaborates with colleagues Tim Costello and Leonard Scott Dove, strengthening the team's efforts in research and development. Their collective expertise plays a crucial role in advancing innovative solutions within the pharmaceutical sector, particularly in designing formulations that mitigate the risks of substance misuse.
Conclusion
In summary, J Michael Davenport stands out as an esteemed inventor in the pharmaceutical landscape, with his patent on opioid receptor modulator dosage formulations. His contributions, along with the support of his talented colleagues at Allergan, are set to play a vital role in addressing the critical issues surrounding opioid medications and their misuse. As healthcare continues to evolve, innovations like those introduced by Davenport offer promising directions for medication safety and efficacy.